Skip to main content
logo
Veraxa Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
1.640
-0.090 (-5.20%)
At close: Aug 26, 2026, 4:00 PM EDT
1.680
+0.040 (2.44%)
Pre-market: Aug 27, 2026, 9:25 AM EDT

Veraxa Biotech AG Balance Sheet

Millions CHF. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Cash & Equivalents
5.3611.35
Cash & Short-Term Investments
5.3611.35
Cash Growth
-52.76%-
Other Receivables
0.170.26
Receivables
0.170.26
Prepaid Expenses
0.070.27
Total Current Assets
5.6111.88
Property, Plant & Equipment
2.832.13
Goodwill
22.8522.85
Other Intangible Assets
53.4955.08
Total Assets
84.7791.94

Liabilities

Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Accounts Payable
0.490.61
Accrued Expenses
0.370.5
Current Portion of Leases
0.16-
Current Income Taxes Payable
0.430.39
Other Current Liabilities
1.10.1
Total Current Liabilities
2.551.61
Long-Term Leases
0.71-
Long-Term Deferred Tax Liabilities
15.1715.79
Other Long-Term Liabilities
35.2919.41
Total Liabilities
53.7136.81

Shareholders' Equity

Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Common Stock
14.1813.41
Retained Earnings
-31.86-3.73
Comprehensive Income & Other
48.7445.45
Shareholders' Equity
31.0555.13
Total Liabilities & Equity
84.7791.94

Additional Metrics

Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Total Debt
0.86-
Net Cash (Debt)
4.511.35
Net Cash Growth
-60.38%-
Net Cash Per Share
0.320.83
Filing Date Shares Outstanding
14.1813.73
Total Common Shares Outstanding
14.1813.73
Working Capital
3.0610.27
Book Value Per Share
2.194.02
Tangible Book Value
-45.28-22.8
Tangible Book Value Per Share
-3.19-1.66
Machinery
2.972.87
Construction In Progress
0.010.01
SEC Filings: 10-K · 10-Q